Read More Pharma Industry News Can ODM-212 validate TEAD inhibition as a viable oncology strategy in mesothelioma? Can Orion Corporation’s ODM-212 prove TEAD inhibition works in mesothelioma? Discover what this FDA orphan designation really signals. bySoujanya RaviApril 22, 2026